Follow the 씨유메디칼 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 씨유메디칼 has logged 35 reports. Market capitalisation: €21.8bn. The latest transaction was disclosed on 13 July 2026 (Other). Among the most active insiders: 엑스큐어. Every trade is openly available.
35
Insider Decl.
n/a
Thresholds
n/a
7 ops.
Buy Volume
n/a
15 ops.
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,705 of 28,134 companies
57.6
score / 100
Value
73
Quality
43
FCF yld39%
Earn yld3.6%
EV/EBITDA9.0x
ROE·
Gross mgn59%
Net mgn1.7%
Debt/EBITDA5.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.